Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Baylor College of Medicine
Baylor College of Medicine
Baylor College of Medicine
National Cancer Institute (NCI)
Xijing Hospital of Digestive Diseases
Chinese University of Hong Kong
Samsung Medical Center
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Shanghai Zhongshan Hospital
City of Hope Medical Center
Pirogov Russian National Research Medical University
City of Hope Medical Center
Centre Hospitalier Universitaire Saint Pierre
Fujian Cancer Hospital
Memorial Sloan Kettering Cancer Center
Chinese University of Hong Kong